ArticleFrontiers in neurology2023

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey.

Sofia Sandgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.